T1	Intervention 85 107	peginterferon alpha 2a
T2	Intervention 130 164	interferon alpha 2b plus ribavirin
T3	Intervention 437 485	peginterferon alpha (pegIFNalpha) 2a monotherapy
T4	Intervention 494 560	combination of interferon alpha (IFNalpha) 2b plus ribavirin (RBV)
T5	Intervention 698 784	open-label treatment with either pegIFNalpha 2a (n = 206) or IFNalpha 2b/RBV (n = 206)
T6	Intervention 786 800	PegIFNalpha 2a
T7	Intervention 887 902	IFNalpha 2b/RBV
T8	Intervention 1008 1041	SF-36 Health Survey Questionnaire
T9	Intervention 1130 1175	Hepatitis Quality of Life Questionnaire (HQLQ
T10	Intervention 1198 1218	pegIFNalpha 2a group
T11	Intervention 1260 1275	IFNalpha 2b/RBV
T12	Intervention 1504 1528	pegIFNalpha 2a treatment
T13	Intervention 1587 1602	IFNalpha 2b/RBV
T14	Intervention 1625 1639	pegIFNalpha 2a
T15	Intervention 1652 1667	IFNalpha 2b/RBV
T16	Intervention 1754 1768	pegIFNalpha 2a
T17	Intervention 1846 1864	prescription drugs
T18	Intervention 1915 1922	therapy
